Literature DB >> 20676837

Characterization of patients with bleeding complications who are at increased risk of death after percutaneous coronary intervention.

Gjin Ndrepepa1, Dritan Keta, Stefanie Schulz, Julinda Mehilli, Anette Birkmeier, Franz-Josef Neumann, Albert Schömig, Adnan Kastrati.   

Abstract

Bleeding complications in patients undergoing percutaneous coronary interventions (PCIs) are associated with increased risk of subsequent mortality. We undertook this study to characterize the subset of patients with bleeding complications who are at an increased risk of death within the first year after a PCI procedure. The study included 331 patients with bleeding complications among 9 954 patients who underwent PCI. The primary outcome analysis was 1-year mortality. Within the first year following PCI there were 39 deaths among 331 patients (11.8%), with bleeding complications and 240 deaths among 9 623 patients without bleeding complications (Kaplan-Meier estimates of 1-year mortality; 11.8% vs 2.5%, odds ratio 5.09, 95% confidence interval 3.76-6.90, P < 0.001). Time to death (median [25th-75th percentiles]) was 38.5 [7.2-125.9] days in patients with bleeding complications vs 137.1 [68.3-234.0] days in patients without bleeding complications (P < 0.001). Compared with survivors (n = 292), nonsurvivors (n = 39) had a significantly more adverse risk profile. The Cox proportional hazards model identified the elevated troponin level as the only independent correlate of 1-year mortality (hazard ratio = 2.35, 95% confidence interval 1.04-5.31, P = 0.039). In conclusion, patients with peri-PCI bleeding complications who die have a more adverse cardiovascular risk profile than patients with bleeding complications who survive the first year after PCI. Patients with bleeding complications and an elevated troponin level are at high risk of death within the first year following PCI. The majority of deaths in patients with peri-PCI bleeding occur within the first 3 months after PCI procedure.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20676837     DOI: 10.1007/s00380-009-1205-7

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  25 in total

1.  Predictors and 1-year outcome of major bleeding in patients with non-ST-elevation acute coronary syndromes: insights from the Canadian Acute Coronary Syndrome Registries.

Authors:  Amit Segev; Bradley H Strauss; Mary Tan; Christian Constance; Anatoly Langer; Shaun G Goodman
Journal:  Am Heart J       Date:  2005-10       Impact factor: 4.749

Review 2.  Non-infectious complications of transfusion therapy.

Authors:  P L Perrotta; E L Snyder
Journal:  Blood Rev       Date:  2001-06       Impact factor: 8.250

3.  Nitric oxide in the human respiratory cycle.

Authors:  Timothy J McMahon; Richard E Moon; Ben P Luschinger; Martha S Carraway; Anne E Stone; Bryant W Stolp; Andrew J Gow; John R Pawloski; Paula Watke; David J Singel; Claude A Piantadosi; Jonathan S Stamler
Journal:  Nat Med       Date:  2002-06-03       Impact factor: 53.440

4.  Profile of bleeding and ischaemic complications with bivalirudin and unfractionated heparin after percutaneous coronary intervention.

Authors:  Raisuke Iijima; Gjin Ndrepepa; Julinda Mehilli; Robert A Byrne; Stefanie Schulz; Franz-Josef Neumann; Gert Richardt; Peter B Berger; Albert Schömig; Adnan Kastrati
Journal:  Eur Heart J       Date:  2009-01-15       Impact factor: 29.983

5.  Antiplatelet therapy use after discharge among acute myocardial infarction patients with in-hospital bleeding.

Authors:  Tracy Y Wang; Lan Xiao; Karen P Alexander; Sunil V Rao; Mikhail N Kosiborod; John S Rumsfeld; John A Spertus; Eric D Peterson
Journal:  Circulation       Date:  2008-11-03       Impact factor: 29.690

6.  Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial.

Authors:  Adnan Kastrati; Julinda Mehilli; Franz-Josef Neumann; Franz Dotzer; Jurriën ten Berg; Hildegard Bollwein; Isolde Graf; Maryam Ibrahim; Jürgen Pache; Melchior Seyfarth; Helmut Schühlen; Josef Dirschinger; Peter B Berger; Albert Schömig
Journal:  JAMA       Date:  2006-03-13       Impact factor: 56.272

7.  Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE).

Authors:  M Moscucci; K A A Fox; Christopher P Cannon; W Klein; José López-Sendón; G Montalescot; K White; R J Goldberg
Journal:  Eur Heart J       Date:  2003-10       Impact factor: 29.983

8.  Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial.

Authors:  Steven V Manoukian; Frederick Feit; Roxana Mehran; Michele D Voeltz; Ramin Ebrahimi; Martial Hamon; George D Dangas; A Michael Lincoff; Harvey D White; Jeffrey W Moses; Spencer B King; E Magnus Ohman; Gregg W Stone
Journal:  J Am Coll Cardiol       Date:  2007-03-09       Impact factor: 24.094

Review 9.  Prudent strategies for elective red blood cell transfusion.

Authors:  H G Welch; K R Meehan; L T Goodnough
Journal:  Ann Intern Med       Date:  1992-03-01       Impact factor: 25.391

10.  Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trial.

Authors:  Gregg W Stone; James H Ware; Michel E Bertrand; A Michael Lincoff; Jeffrey W Moses; E Magnus Ohman; Harvey D White; Frederick Feit; Antonio Colombo; Brent T McLaurin; David A Cox; Steven V Manoukian; Martin Fahy; Tim C Clayton; Roxana Mehran; Stuart J Pocock
Journal:  JAMA       Date:  2007-12-05       Impact factor: 56.272

View more
  2 in total

1.  Applying the National Institute for Clinical Excellence criteria to patients treated with the Genous™ Bio-engineered R stent™: a sub-study of the e-HEALING (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth) worldwide registry.

Authors:  Margo Klomp; Peter Damman; Marcel A M Beijk; Sigmund Silber; Manfred Grisold; Expedito E Ribeiro; Harry Suryapranata; Jaroslaw Wòjcik; Kui Hian Sim; Jan G P Tijssen; Robbert J de Winter
Journal:  Heart Vessels       Date:  2011-07-02       Impact factor: 2.037

2.  Comparison between sirolimus- and paclitaxel-eluting stents for the treatment of older patients affected by coronary artery disease: results from a single-center allcomers registry.

Authors:  Paolo Buja; Davide Lanzellotti; Giambattista Isabella; Massimo Napodano; Marco Panfili; Enrico Favaretto; Sabino Iliceto; Giuseppe Tarantini
Journal:  Heart Vessels       Date:  2011-10-12       Impact factor: 2.037

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.